Report: Most anti-diabetic meds can slow cognitive decline
By
Kristen Fischer
Nov 29, 2023
For the most part, oral anti-diabetic (OAD) medications can help slow cognitive decline and reduce the risk and incidence of dementia as a complication of type 2 diabetes, a new report has found.
Stopping metformin is linked to dementia, study finds
By
Kristen Fischer
Oct 26, 2023
A new study published Wednesday in JAMA Network Opens shows that stopping metformin is linked with increased dementia incidence.
Clinical briefs for Tuesday, Aug. 15
By
Kristen Fischer
Aug 15, 2023
Heart group urges better shared decision-making … Metformin studied for muscle recovery … Pros, cons of shifting meds in older adults with diabetes … Long COVID numbers on the way down, but symptoms...
Common diabetes drug may serve as novel Afib treatment
By
Alicia Lasek
Oct 13, 2022
If approved, it would be the first new drug identified to treat this disease of the heart in a decade, according to Cleveland Clinic researchers.
Clinical briefs for Friday, Aug. 19
By
Alicia Lasek
Aug 19, 2022
Senior living operator adds resident rehab options with recovery technology partnership … Diabetes drug metformin may greatly reduce severe COVID outcomes, clinical trial finds … Rosuvastatin linked...
Use of certain prescription meds linked to COVID-19 mortality
Jan 10, 2022
Discontinuation of ACE-I, ARB, metformin associated with elevated risk for death among hospitalized COVID-19 patients
After decade of progress, diabetes control loses steam as first-line therapies go underused
By
Alicia Lasek
Jun 11, 2021
Reinvigorating the use of first-line therapies such as statins, metformin, ACE inhibitors or ARB is key to getting care and outcomes back on track, investigators say.
Metformin may prevent a common cause of vision loss in aging
By
Alicia Lasek
Feb 01, 2021
The diabetes drug metformin may protect against age-related macular degeneration, a potentially blinding condition for which there appears to be no effective preventive measures, researchers contend.
Clinical briefs for Monday, Dec. 14
Dec 13, 2020
COVID-19 can induce seizures and movement disorders, even in moderate cases … CDC reports record flu vaccine distribution in a so-far mild season … FDA OKs first non-prescription, at-home COVID test...
Metformin may slow cognitive decline in people with diabetes
By
Alicia Lasek
Sep 25, 2020
Researchers have found new potential for a safe and widely used medication. The discovery could be “life-changing” for patients at risk of dementia, they say.